Remyelination therapies on trial

Previous research suggests that opicinumab treatment might enhance remyelination. Results from a phase 2 clinical trial testing the

research assistant

Be a part of changing the future

MS research could not advance without the help of people living with MS – here are some ways to be part of changing the future.

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Central Nervous System – MS in a minute